Codi QR

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production...

Descripció completa

Guardat en:
Autors principals: Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, Long Van Pham, Shan Feng, Ulrik Fahnøe, Troels Kasper Høyer Scheel, Santseharay Ramirez, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith Margarete Gottwein
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2021-06-01
Col·lecció:Vaccines
Matèries:
severe acute respiratory syndrome coronavirus 2
COVID-19
scalable bioreactor
CelCradle
packed-bed
whole virus vaccine
Accés en línia:https://www.mdpi.com/2076-393X/9/7/706
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars